North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension [PDF]
, 2022 Complications of portal hypertension, including ascites, gastrointestinal bleeding, hepatic hydrothorax, and hepatic encephalopathy, are associated with significant morbidity and mortality.
Boike, Justin R +2 more
core +5 more sources
Development of pseudointima and stenosis after transjugular intrahepatic portasystemic shunts: Characterization of cell phenotype and function [PDF]
Hepatology, 1998 The clinical utility of transjugular intrahepatic portasystemic shunts (TIPS) is frequently complicated by the ingrowth of tissue into the stent lumen, causing stent stenosis. These studies were undertaken to define the cellular and matrix components of the pseudointima, define the phenotype and function of the mesenchymal ...
Amy Willey +5 more
openaire +3 more sources
Primary prevention and management of variceal bleeding: Review of Historical Evidence [PDF]
, 2008 Background: Prevention and control of active bleeding caused by portal hypertension is still a challenge. Surgery used to be the only option in the earlier days, but now many options exist.
Suliman, MOM
core +2 more sources
Effect of transjugular intrahepatic portosystemic shunt on transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis [PDF]
, 2021 PURPOSEHepatocellular carcinoma (HCC) usually occurs accompanied by portal hypertension. Transcatheter arterial chemoembolization (TACE) is recommended as an effective treatment in HCC.
Fei Gao +5 more
core +1 more source
Endothelial Cells Lining Transjugular Intrahepatic Portasystemic Shunts Originate in Hepatic Sinusoids: Implications for Pseudointimal Hyperplasia [PDF]
Hepatology, 1999 The phenotype of the endothelial cells (ECs) in the pseudointima of transjugular intrahepatic portasystemic shunts (TIPS) and the mechanisms of pseudointima formation after TIPS were unknown. We hypothesized that TIPS were lined by hepatic sinusoidal ECs, which stimulated the migration of smooth muscle cells (SMCs) into the ...
Arun J. Sanyal, Faridoddin Mirshahi
openaire +3 more sources
Arquivos de Gastroenterologia, 2001 Diversas alternativas terapêuticas têm sido usadas, atualmente, na tentativa de reduzir a mortalidade de pacientes com hipertensão portal que desenvolvem varizes esofagianas.
Gerson CARREIRO +4 more
doaj +1 more source
Gut and Liver, 2018 Background/Aims Gastric varices (GVs) are a major cause of upper gastrointestinal bleeding in patients with liver cirrhosis. The current treatments of choice are balloon-occluded retrograde transvenous obliteration (BRTO) and the placement of a ...
Geunwu Gimm +8 more
doaj +1 more source
Gastrointestinal Intervention, 2018 Background: To evaluate the safety and efficacy of transjugular intrahepatic portosystemic shunt (TIPS) creation for the management of portal hypertension in patients with hepatocellular carcinoma (HCC). Methods: A literature search of the MEDLINE/PubMed
He Zhao +5 more
doaj +1 more source
Could there be light at the end of the tunnel? Mesocaval shunting for refractory esophageal varices in patients with contraindications to transjugular intrahepatic portosystemic shunt. [PDF]
, 2016 Cirrhotic patients with recurrent variceal bleeds who have failed prior medical and endoscopic therapies and are not transjugular intrahepatic portosystemic shunt candidates face a grim prognosis with limited options.
Borum, Marie L +2 more
core +2 more sources
The Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension: Current Status [PDF]
, 2012 The transjugular intrahepatic portosystemic shunt (TIPS) represents a major advance in the treatment of complications of portal hypertension. Technical improvements and increased experience over the past 24 years led to improved clinical results and a ...
Dave Guérette +5 more
core +2 more sources